基于GoPubMed对慢性非传染性疾病患者药学监护研究的文献计量学分析
|
摘要
目的:了解全球对慢性非传染性疾病(以下简称"慢病")患者药学监护的研究现状。方法:在GoPubMed网站首页搜索框内输入"‘Chronic Disease’[mesh] AND ‘Pharmaceutical Care’[mesh]"进行检索,搜集PubMed数据库中关于对慢病患者药学监护的文献,检索时限为建库至2018年6月19日,利用Go Pub Med网站的统计功能,分析相关文献的发表年份、主题、国家和刊载期刊等情况。结果:共检索到4 110篇文献。2008年以来每年发表相关文献超过200篇。发表对慢病患者药学监护相关文献较多的国家依次是美国(1 530篇)、英国(266篇)和加拿大(233篇),我国发表相关文献76篇。结论:近年来对慢病患者药学监护相关研究日益受到关注,我国相关研究较少,做好对慢病患者药学监护的实践与研究对于保障患者用药安全、充分发挥药师专业作用具有重要意义。
Objective: To explore the current research status of pharmaceutical care for chronic disease.Methods: Enter"Chronic Disease"[mesh] AND "Pharmaceutical Care"[mesh] in the search box of the Go Pub Med website to collect all relevant documents collected by the Pub Med database from inception to June 19,2018,and use the statistical function of Go Pub Med. Analyze the publication year,subject,country and published journals of relevant literature. Results: A total of 4 110 articles related to pharmaceutical care for chronic disease were retrieved. Since 2008,more than 200 related literatures had been published each year. The countries that publish more literature on pharmaceutical care for chronic disease were the United States( 1 530),the United Kingdom( 266),and Canada( 233),and 76 articles had been published in China. Conclusion: In recent years,the research on pharmaceutical care for chronic disease has received increasing attention,but there are few relevant studies in China. The practice and research of pharmacological monitoring of patients with chronic diseases are of great importance to ensure the safety of patients' medication and give full play to the professional role of pharmacists.
Objective: To explore the current research status of pharmaceutical care for chronic disease.Methods: Enter"Chronic Disease"[mesh] AND "Pharmaceutical Care"[mesh] in the search box of the Go Pub Med website to collect all relevant documents collected by the Pub Med database from inception to June 19,2018,and use the statistical function of Go Pub Med. Analyze the publication year,subject,country and published journals of relevant literature. Results: A total of 4 110 articles related to pharmaceutical care for chronic disease were retrieved. Since 2008,more than 200 related literatures had been published each year. The countries that publish more literature on pharmaceutical care for chronic disease were the United States( 1 530),the United Kingdom( 266),and Canada( 233),and 76 articles had been published in China. Conclusion: In recent years,the research on pharmaceutical care for chronic disease has received increasing attention,but there are few relevant studies in China. The practice and research of pharmacological monitoring of patients with chronic diseases are of great importance to ensure the safety of patients' medication and give full play to the professional role of pharmacists.
引文
1 Hepler CD,Strand LM.Opportunities and responsibilities in pharmaceutical care[J].Am J Hosp Pharm,1990,47(3):533-543
2 Cristina C,Hendrik,Colleen W.Chronic care management for the elderly:an opportunity for gerontological nurse practitioners[J].J Am Acad Nurse Pract,2005,17(7):263-267
3 Berenson RA.Confronting the barriers to chronic care mallagement in medicare[J].Health Affairs,2003(2):337-353
4 Mathers CD,Loncar D.Projections of global mortality and burden of disease from 2002 to 2030[J].PLo S Med,2006,3(11):e442
5田华,李沭,张相林.慢病管理模式的国内外现状分析[J].中国药房,2016,27(32):4465-4468
6 Grover A,Joshi A.An overview of chronic disease models:a systematic literature review[J].Glob J Health Sci,2015,7(2):210-227
7 Bodenheimer T,Wagner EH,Grumbach K.Improving primary care for patients with chronic illness[J].JAMA,2002,288(14):1775-1179
8 Naylor MD,Brooten DA,Campbell RL,et al.Transitional care of older adults hospitalized with heart failure:a randomized,controlled trial[J].J Am Geriatr Soc,2004,52(5):675-684
9 Freeman G,Shepperd S,Robinson I,et al.Continuity of Care:Report of a Scoping Exemise for NHS Service Delivery and Organisation R&D[M].London:NIHR servicedelivery and organisation,2001:41-43
10 Lefeber GJ,Drenth-van Maanen AC,Wilting I,et al.Effect of a transitional pharmaceutical care intervention at hospital discharge on registration of changes in medication regimens in primary care[J].J Am Geriatr Soc,2014,62(3):565-567
11 Neeman M,Dobrinas M,Maurer S,et al.Transition of care:A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine ward[J].Eur J Intern Med,2017,38:30-37
12 Garcia-Caballos M,Ramos-Diaz F,Jimenez-Moleon JJ,et al.Drug-related problems in older people after hospital discharge and interventions to reduce them[J].Age Ageing,2010,39(4):430-438
13 Ohno Y,Heima T,Ishikawa T,et al.Promoting Appropriate Pharmacotherapy for Home Care Patients:Coordination between Regional Comprehensive Support Centers and Pharmacies[J].Gan To Kagaku Ryoho,2016,43(1):17-20
14 Steele KM,Ruisinger JF,Bates J,et al.Home-Based Comprehensive Medication Reviews:Pharmacist’s Impact on Drug Therapy Problems in Geriatric Patients[J].Consult Pharm,2016,31(10):598-605
15庄咏翔.云端药历系统应用于药事居家照护[J].(中国台湾)药学杂志,2014,30(3):137-140
16 Snider M,Carnes C,Grover J,et al.Cost-benefit and costsavings analyses of antiarrhythmic medication monitoring[J].Am J Health Syst Pharm,2012,69(18):1569-1573
17 Desborough JA,Sach T,Bhattacharya D,et al.A costconsequences analysis of an adherence focused pharmacistled medication review service[J].Int J Pharm Pract,2012,20(1):41-49
18 Simpson SH,Lier DA,Majumdar SR,et al.Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with type 2 diabetes:results from a randomized controlled trial[J].Diabet Med,2015,32(7):899-906
19 Garwood CL,Curtis KD,Belanger GJ,et al.Preliminary data from a pharmacist-managed anticoagulation clinic embedded in a multidisciplinary patient-centered medical home:a coordinated quality,cost-savings model[J].J Am Geriatr Soc,2014,62(3):536-540
2 Cristina C,Hendrik,Colleen W.Chronic care management for the elderly:an opportunity for gerontological nurse practitioners[J].J Am Acad Nurse Pract,2005,17(7):263-267
3 Berenson RA.Confronting the barriers to chronic care mallagement in medicare[J].Health Affairs,2003(2):337-353
4 Mathers CD,Loncar D.Projections of global mortality and burden of disease from 2002 to 2030[J].PLo S Med,2006,3(11):e442
5田华,李沭,张相林.慢病管理模式的国内外现状分析[J].中国药房,2016,27(32):4465-4468
6 Grover A,Joshi A.An overview of chronic disease models:a systematic literature review[J].Glob J Health Sci,2015,7(2):210-227
7 Bodenheimer T,Wagner EH,Grumbach K.Improving primary care for patients with chronic illness[J].JAMA,2002,288(14):1775-1179
8 Naylor MD,Brooten DA,Campbell RL,et al.Transitional care of older adults hospitalized with heart failure:a randomized,controlled trial[J].J Am Geriatr Soc,2004,52(5):675-684
9 Freeman G,Shepperd S,Robinson I,et al.Continuity of Care:Report of a Scoping Exemise for NHS Service Delivery and Organisation R&D[M].London:NIHR servicedelivery and organisation,2001:41-43
10 Lefeber GJ,Drenth-van Maanen AC,Wilting I,et al.Effect of a transitional pharmaceutical care intervention at hospital discharge on registration of changes in medication regimens in primary care[J].J Am Geriatr Soc,2014,62(3):565-567
11 Neeman M,Dobrinas M,Maurer S,et al.Transition of care:A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine ward[J].Eur J Intern Med,2017,38:30-37
12 Garcia-Caballos M,Ramos-Diaz F,Jimenez-Moleon JJ,et al.Drug-related problems in older people after hospital discharge and interventions to reduce them[J].Age Ageing,2010,39(4):430-438
13 Ohno Y,Heima T,Ishikawa T,et al.Promoting Appropriate Pharmacotherapy for Home Care Patients:Coordination between Regional Comprehensive Support Centers and Pharmacies[J].Gan To Kagaku Ryoho,2016,43(1):17-20
14 Steele KM,Ruisinger JF,Bates J,et al.Home-Based Comprehensive Medication Reviews:Pharmacist’s Impact on Drug Therapy Problems in Geriatric Patients[J].Consult Pharm,2016,31(10):598-605
15庄咏翔.云端药历系统应用于药事居家照护[J].(中国台湾)药学杂志,2014,30(3):137-140
16 Snider M,Carnes C,Grover J,et al.Cost-benefit and costsavings analyses of antiarrhythmic medication monitoring[J].Am J Health Syst Pharm,2012,69(18):1569-1573
17 Desborough JA,Sach T,Bhattacharya D,et al.A costconsequences analysis of an adherence focused pharmacistled medication review service[J].Int J Pharm Pract,2012,20(1):41-49
18 Simpson SH,Lier DA,Majumdar SR,et al.Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with type 2 diabetes:results from a randomized controlled trial[J].Diabet Med,2015,32(7):899-906
19 Garwood CL,Curtis KD,Belanger GJ,et al.Preliminary data from a pharmacist-managed anticoagulation clinic embedded in a multidisciplinary patient-centered medical home:a coordinated quality,cost-savings model[J].J Am Geriatr Soc,2014,62(3):536-540